Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.

 

Category: Pharmacology

Establishing Pharmacy Services in an Alternate Care Site

This presentation discusses how to best organize a pharmacy at an alternate care site. This is SCCM curated COVID-19 microlearning content.

Analgesic, Sedative, and Paralytic Strategies in COVID-19 Patients During Critical Shortages

This presentation provides an overview of strategies for triaging analgesic, sedative, and paralytic agents patients with COVID-19. This is SCCM curated COVID-19 microlearning content.

   Estimated Time: 07:50 min Coronavirus, COVID-19, Sedation, Therapies, Triage

Subcutaneous Enoxaparin Safely Facilitates Bedside Sustained Low-Efficiency Hemodialysis in Hypercoagulopathic Coronavirus Disease 2019 Patients - A Proof-of-Principle Trial

This study describes a simple and safe protocol of anticoagulation with low molecular weight heparin (LMWH) in combination with bedside sustained low efficiency hemodialysis (SLED) in COVID-19 patients.

   Estimated Time: 09:16 min Anticoagulation, Coronavirus, COVID-19

Tocilizumab for Cytokine Storm in COVID-19

This presentation provides an overview of the types of strategies for enhancing sleep in patients with COVID-19. This is SCCM curated COVID-19 microlearning content.

   Estimated Time: 02:30 min Coronavirus, COVID-19, Therapies

Intubation Medications/Sedation Requirements for Intubating COVID-19 Patient - Infographic

This resource is an infographic that details intubation medications and sedation requirement for intubating COVID-19 patients. This is a community developed COVID-19 microlearning resource.

   Estimated Time: 02:00 min Coronavirus, COVID-19, Sedation, Supportive Care

Is there any research on the prevalence of vitamin D deficiencies in COVID-19 patients?

In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues. Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Gr...

   Estimated Time: 01:12 min Coronavirus, COVID-19, Diagnosis and Testing

Strategies During NeuroMuscular Blocking Agent (NMBA) Shortages

This presentation covers how to manage neuromuscular blocking agent (NMBA) shortages. This is SCCM curated COVID-19 microlearning content.

   Estimated Time: 04:36 min Coronavirus, COVID-19, Sedation, Therapies

Can you discuss coagulability issues?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered. This microlearning content was taken from the COVID-19 Critical Care for Non-ICU Clinicians: Expert Panel Series held on May 13th, 2020.

   Estimated Time: 06:47 min Anticoagulation, Coronavirus, COVID-19

Coagulopathy of Coronavirus Disease 2019

From Critical Care Medicine. Recent studies have reported a high incidence of thrombotic events in COVID-19. However, the significance of thromboembolic complications has not been widely appreciated. The purpose of this review is to provide current knowledge of this serious pr...

   Estimated Time: 24:24 min Anticoagulation, Coronavirus, COVID-19, Therapies

Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019

From Critical Care Medicine. The authors sought to determine the frequency of venous thromboembolism in critically ill coronavirus disease 2019 patients and associate a degree of inflammatory marker elevation to venous thromboembolism development. They found that routine chemi...

   Estimated Time: 24:31 min Coronavirus, COVID-19, Therapies

Strategies to Approach Drug Shortages of Analgesics and Sedatives During COVID-19

This presentation provides an overview of the types of strategies for approaching the C Element (Choice of Analgesia & Sedation) of the ICU Liberation Bundle in patients with COVID-19. This is SCCM curated COVID-19 microlearning content.

   Estimated Time: 04:30 min Coronavirus, COVID-19, ICU Liberation, Therapies

What are your thoughts on anticoagulation treatment?

In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues.

   Estimated Time: 04:15 min Anticoagulation, Coronavirus, COVID-19, Therapies

What are your thoughts on COVID-19 treatments?

In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues.

   Estimated Time: 02:18 min Coronavirus, COVID-19, Therapies

Are there any updates on using steroids to treat patients with COVID-19?

In this question and answer webcast series, attendees had an opportunity to pose questions about managing critically ill patients with COVID-19 and other issues.

   Estimated Time: 03:56 min Coronavirus, COVID-19, Therapies

Ramifications of COVID-19 Pandemic on Pharmacy Daily Workflow

This presentation describes the ramification on daily workflow when working on the frontines during the pandemic. This is SCCM curated COVID-19 microlearning content.

   Estimated Time: 11:34 min Coronavirus, COVID-19, Resource Allocation, Therapies, Triage

Letter to the Editor: Evidence of Steroids in Patients With Acute Respiratory Distress Syndrome in Coronavirus Disease 2019

From Critical Care Explorations. A letter to the editor in response to Villar et al. article on corticosteroids and COVID-19.

   Estimated Time: 05:21 min ARDS, Coronavirus, COVID-19, Therapies

Comparing the Surviving Sepsis Campaign (SSC) and National Institutes of Health (NIH) COVID-19 Guidelines

This webcast was an SCCM COVID-19 expert panel discussion comparing the Surviving Sepsis Campaign COVID-19 Guidelines with the newly released National Institutes of Health Coronavirus (COVID-19) Treatment Guidelines.

   Estimated Time: 58:50 min Coronavirus, COVID-19, Infection Control, Supportive Care, Therapies

What is the recommended role of serial laboratory studies, including troponin, creatin kinase and D-dimer in the management of a hypercoagulable state?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered.

   Estimated Time: 02:11 min Anticoagulation, Clinical Trials, Coronavirus, COVID-19, Therapies

What new drugs are available for COVID-19?

Questions from social media, blogs and the various discussion forums, including the new SCCM COVID-19 Discussion Group, were answered.

   Estimated Time: 02:53 min Coronavirus, COVID-19, Therapies

Fact Versus Science Fiction: Fighting Coronavirus Disease 2019 Requires the Wisdom to Know the Difference

From Critical Care Explorations. This commentary uses a recent study of hydroxychloroquine to demonstrate the dire need for randomized clinical trials, but more importantly, to explore the potential consequences of misinformation, how fear fuels its impact, and offer guidance ...

   Estimated Time: 07:46 min Coronavirus, COVID-19